↓ Skip to main content

Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?

Overview of attention for article published in Neuropharmacology, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs
2 blogs
policy
2 policy sources
twitter
5 X users

Citations

dimensions_citation
186 Dimensions

Readers on

mendeley
515 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
Published in
Neuropharmacology, June 2012
DOI 10.1016/j.neuropharm.2012.06.020
Pubmed ID
Authors

Asli Demirtas-Tatlidede, Andrew M. Vahabzadeh-Hagh, Alvaro Pascual-Leone

Abstract

Cognitive impairment is a core symptom of many neuropsychiatric diseases and a key contributor to the patient's quality of life. However, an effective therapeutic strategy has yet to be developed. Noninvasive brain stimulation techniques, namely transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), are promising techniques that are under investigation for a variety of otherwise treatment-resistant neuropsychiatric diseases. Notably, these tools can induce alterations in neural networks subserving cognitive operations and thus may provide a means for cognitive restoration. The purpose of this article is to review the available evidence concerning cognitive enhancing properties of noninvasive brain stimulation in neuropsychiatry. We specifically focus on major depression, Alzheimer's disease, schizophrenia, autism and attention deficit hyperactivity disorder (ADHD), where cognitive dysfunction is a major symptom and some studies have been completed with promising results. We provide a critical assessment of the available research and suggestions to guide future efforts. This article is part of a Special Issue entitled 'Cognitive Enhancers'.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 515 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 6 1%
Spain 4 <1%
United Kingdom 3 <1%
Brazil 2 <1%
Italy 2 <1%
Germany 2 <1%
Israel 1 <1%
India 1 <1%
Netherlands 1 <1%
Other 8 2%
Unknown 485 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 93 18%
Student > Ph. D. Student 78 15%
Student > Master 77 15%
Student > Bachelor 63 12%
Student > Postgraduate 27 5%
Other 89 17%
Unknown 88 17%
Readers by discipline Count As %
Psychology 133 26%
Medicine and Dentistry 82 16%
Neuroscience 78 15%
Agricultural and Biological Sciences 41 8%
Engineering 13 3%
Other 53 10%
Unknown 115 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#1,789,571
of 25,708,267 outputs
Outputs from Neuropharmacology
#241
of 4,835 outputs
Outputs of similar age
#10,309
of 178,195 outputs
Outputs of similar age from Neuropharmacology
#12
of 91 outputs
Altmetric has tracked 25,708,267 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,835 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,195 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.